WO2000054735A1 - Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use - Google Patents

Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use Download PDF

Info

Publication number
WO2000054735A1
WO2000054735A1 PCT/EP2000/001974 EP0001974W WO0054735A1 WO 2000054735 A1 WO2000054735 A1 WO 2000054735A1 EP 0001974 W EP0001974 W EP 0001974W WO 0054735 A1 WO0054735 A1 WO 0054735A1
Authority
WO
WIPO (PCT)
Prior art keywords
micromixer
mixed
components
storage chambers
passed
Prior art date
Application number
PCT/EP2000/001974
Other languages
German (de)
French (fr)
Inventor
Jutta Zur Lage
Hans-Jürgen DRILLER
Joachim BÜNGER
Annette Wagner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority to CA002367391A priority Critical patent/CA2367391A1/en
Priority to JP2000604813A priority patent/JP2002538947A/en
Priority to AU39611/00A priority patent/AU768399B2/en
Priority to EP00918767A priority patent/EP1161221A1/en
Publication of WO2000054735A1 publication Critical patent/WO2000054735A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/068Microemulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/066Multiple emulsions, e.g. water-in-oil-in-water
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30Micromixers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/21Mixing of ingredients for cosmetic or perfume compositions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22Mixing of ingredients for pharmaceutical or medical compositions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40Mixing liquids with liquids; Emulsifying
    • B01F23/41Emulsifying

Definitions

  • the present invention relates to a method for producing cosmetic or pharmaceutical formulations immediately before use, two or more liquid components from separate storage chambers being intimately mixed with one another by passing the liquid components through a micromixer. Furthermore, the present invention also relates to the lotions, emulsions, gels, creams and solutions produced by the process according to the invention, either for cosmetic use or, if appropriate pharmaceutical active ingredients have been incorporated, the pharmaceutical formulations prepared.
  • mixing is to be understood as basic operations which serve the greatest possible homogenization of substances.
  • Material flows should be combined in such a way that the individual components are composed as evenly as possible in partial volumes of the resulting mixture.
  • Homogenization is a special form of mixing. This is understood to mean mixing phases that are not miscible with one another. Homogenization is understood to mean changing the distribution state and particle size of the inner phase of emulsions and suspensions, so that microscopically, a homogeneous system is created and the distributed phase does not settle or cream without the action of external forces.
  • Dispersing is understood to mean a mixing of a material system consisting of two (or more) phases, in which one substance (disperse phases) is mixed in another (dispersion medium) in the finest form. divides (disperses). Both the particles of the disperse phase and the dispersant can be solid, liquid or gaseous. Examples of dispersions are aerosols, emulsions, suspensions and colloids.
  • emulsification Another type of mixing that is common in cosmetics production is emulsification. This is understood to mean mixing two liquids which are insoluble or only slightly soluble in one another, one of which is finely distributed in the other.
  • the outer phase is referred to as the continuous phase or as a dispersant, the liquid distributed therein as the inner, discontinuous or disperse phase.
  • Cosmetic emulsions mostly consist of an aqueous polar phase and a non-polar oil phase.
  • Suspending in turn means the distribution of very small, but not molecular, particles of a solid in a liquid.
  • Suspensions like emulsions, are usually optically cloudy and tend to settle under the influence of gravity.
  • Emulsification processes are usually carried out according to the following scheme: Two substances that are insoluble in each other, namely fat and water, are mixed. In order to obtain a durable emulsion, the fat and water phases have to be mechanically crushed to below 10 ⁇ m and then stabilized with the help of an emulsifier. Normally, the oil and fat phases are introduced separately, heated to 50 - 70 ° C and then pre-emulsified. All water-soluble substances are in the water phase, all fat-soluble substances in the fat phase.
  • the pre-emulsion produced after the hot / hot process (both phases are heated separately to 50-70 ° C) is cooled to room temperature before the addition of perfume oil and dye and then emulsified.
  • Simple mixing vessels with different types of stirrers are often used to produce cosmetic formulations.
  • type of stirrer e.g. anchor, propeller, inclined blade, disc, EKATO-MIG stirrer, EKATO-Mizer disc
  • EKATO-Mizer disc e.g. anchor, propeller, inclined blade, disc, EKATO-MIG stirrer, EKATO-Mizer disc
  • 35 emulsions can arise in which the emulsified phase is very has different particle sizes, or the active ingredient distribution in a manufactured product is uneven.
  • the object of the invention is achieved by a process for the production of cosmetic or pharmaceutical formulations immediately before use, characterized in that two or more liquid components from separate storage chambers are mixed with one another by being passed through a micromixer.
  • two or more components can be passed in liquid form for mixing through a micromixer from separate storage chambers.
  • Mixing can be carried out by passing the components from separate storage chambers, if necessary after heating, in liquid form through a temperature-controlled micromixer and stirring them if necessary to cool them down.
  • one or more liquid component (s) with one or more natural, synthetic or semi-synthetic oil (s) can be passed from separate storage chambers through a micromixer, mixing them together.
  • the object of the invention is also achieved by a process for the production of cosmetic formulations in the form of emulsions immediately before use, characterized in that a fat phase consisting of one or more natural, synthetic or semisynthetic oil (s) and one or more of Fat (s) which are solid at room temperature are liquefied in a storage chamber by heating, and this liquid fat phase is mixed with one or more liquid component (s) and optionally with another oil phase by passing them through a micromixer.
  • a fat phase consisting of one or more natural, synthetic or semisynthetic oil (s) and one or more of Fat (s) which are solid at room temperature are liquefied in a storage chamber by heating, and this liquid fat phase is mixed with one or more liquid component (s) and optionally with another oil phase by passing them through a micromixer.
  • the components to be mixed are pumped out of the storage chambers and are passed into the micromixer through subsequent thin tubes, which each end in a channel of a micromixer, and through the channels of the pump due to the pressure building up as a result of the pumping Micromixer are pressed with intensive mixing and formation of an emulsion.
  • the components to be mixed from pressurized storage chambers through subsequent thin tubes, which each end in a channel of a micromixer, to guide the components into the micromixer and through the channels of the micromixer due to the build-up Pressure with intensive mixing and formation of an emulsion.
  • the object of the invention is further achieved by a process for the preparation of liposome-containing formulations immediately before use, by one or more liquid component ⁇ ) with a component which contains liposome-forming ingredients O 00/54735 - 6 - PCT / EPOO / 01974
  • the components to be mixed can be conveyed from pressurized storage chambers and passed into the micromixer through adjoining thin tubes, which each end in a channel of a micromixer. Due to the pressure coming from the storage chambers, a sufficient pressure is built up in the micromixer, by means of which the components are pressed through the channels with intensive mixing and formation of a liposome-helpful formulation.
  • the present object is also achieved by means of lotions or solutions, emulsions, gels and creams which can be produced by the process according to the invention.
  • mixtures in the form of emulsions, suspensions and dispersions, lotions, solutions, gels and creams are possible, in which all ingredients are evenly distributed in the smallest parts by volume.
  • these mixtures can also be produced in the micro range under uniform temperature conditions, since the thin, possibly laminate-like no temperature drop forms, especially if the micromixer is designed for temperature control.
  • the energy input is the same in every, ie even in the smallest part of the volume. It has also been found that emulsions can be produced with a much more homogeneous droplet size distribution than in a stirred vessel.
  • micromixer Due to the multiple shear conditions of the communicating channels in the micromixer, droplet sizes in the micro range are inevitable, so that microemulsions are obtained which could only be produced in a stirred vessel in a very complex manner.
  • the use of a micromixer is therefore suitable for the production of very fine, homogeneous formulations.
  • Micromixers, associated connection and closure systems are suitable for carrying out the method according to the invention, which are described in patent applications DE 1 95 11 603, DE 1 97 46 583, DE 1 97 46 584,
  • Suitable micromixers can consist of suitable metallic, ceramic, polymeric materials or silicon.
  • Emulsions in the W / O field are emulsions, in particular those with high levels of vegetable triglycerides.
  • Emulsions without stabilizing waxes are often characterized by insufficient long-term viscosity constancy and OW lotions are generally more difficult to stabilize than creams.
  • These emulsions can therefore be produced particularly well using micromixers. It is particularly advantageous here that particularly small quantities can be produced by using micromixers, which advantageously in situ, i. H. can be made directly before use.
  • Microemulsions are thermodynamically stable if they arise spontaneously due to extremely low interfacial energy, that is, without the addition of external mechanical energy.
  • the droplet diameters are much smaller than with macroemulsions, they are in the range of 10-30 nm (nanometers), which means below the wavelength of visible light. Microemulsions are therefore colloidally disperse, optical transparent systems. According to POHLER, certain concentration ranges of the oil and water phases as well as the emulsifiers and auxiliary substances must be observed when formulating microemulsions:
  • Surfactants (mostly non-ionic surfactants) 15 - 40%
  • micromixers for the production of microemulsions makes it possible to considerably reduce the use of surfactants, so that the tolerance for particularly sensitive skin types can be significantly increased.
  • Stable microemulsions can be produced using less than 10% by weight of surfactants.
  • micromixers makes it possible to produce very small amounts of the desired cosmetic or pharmaceutical formulations immediately before use.
  • This has the advantage that the addition of emulsifiers, suspension and dispersion aids in the form of surfactants and other additives such as. B. stabilizers can be very limited or their use can be omitted entirely.
  • active ingredients or additives which are not compatible with one another in a formulation for a long time only immediately before use. Active ingredients that are only stable in the form of a derivative in a formulation, can be presented as such in a separate formulation and added directly before the rest of the mixture is used.
  • the user can also add different additives to small quantities of a base mixture at different times, as required. This can be of interest for both pharmaceutical and cosmetic formulations if different active ingredients are to be applied at different times.
  • additives can be added to a basic cosmetic formulation for the day than for the night.
  • Additives for the day can be UV filters, for example, while regenerative additives for the night.
  • Phases A, B and C are each placed separately in a storage container and heated to 75 ° C.
  • the thus liquid phases B and C are pumped out of the storage containers and passed through a micromixer heated to 75 ° C. and mixed.
  • the mixture emerging from the micromixer is then pumped with phase A through a micromixer heated to 75 ° C. and homogenized.
  • the emulsion obtained is in a
  • Viscosity 43000 mPa.s (Brookfield RVT, spindle C, 5 rpm, Helipath) at 25 ° C 0.05% propyl 4-hydroxybenzoate (Merck KGaA, item no.130173), 0.15% methyl 4- hydroxybenzoate (Merck KGaA, Art. No. 13 0174), 0.30% Germall 115 (ISP, Frechen)
  • Both phases A and B are placed separately in a storage container. After mixing, which can be done either by stirring or by shaking in small vessels, the phases are pumped out of the storage containers and passed together through a micromixer, in which the phases are mixed intensively.
  • the homogeneously mixed milk can be used directly.
  • Glycerin (Item No. 4093) (1) 5.00
  • phase B tris (hydroxymethyl) aminomethane is dissolved in water in a storage vessel to neutralize Eusolex 232 and Eusolex 232 is added. After the solution has been completely dissolved, the remaining phase B raw materials are added. The components of phase A are premixed in a second storage vessel.
  • the two mixing phases are pumped together with the help of a pump through a micromixer connected via thin connecting tubes.
  • Viscosity 22,800 mPas (Brookfield RVT, Sp. C, 10 rpm) at 25 'C samples contain 0.05% propyl 4-hydroxybenzoate as a preservative (Merck item no. 7427)
  • Eumulgin B2 cetiol HE, Uniphen P-23 and the paraffin oil are placed in a storage vessel, melted while mixing and heated to approx. 95 ° C-105 ° C.
  • the water phase and the fat phase are pumped through a micromixer for intensive mixing.
  • the resulting microemulsion gel was stirred to cool.
  • microemulsion gel it is possible to pass the microemulsion gel through a further cooled micromixer, the outgoing channels of which have a further cross section, as a result of which the channels are not clogged and the formation of air pockets in the gel is prevented.
  • Example 5 At a temperature at which the microemulsion gel is just pourable, it is filled into the primary packaging.
  • phase C disperse the Pemulen TR-1 homogeneously in the water, add the preservative and swell. Enter phase B under homogenization in phase C. Dissolve phase A while heating and add slowly while homogenizing. Add phase D at 35 ° C and homogenize again.
  • Vitamin E acetate 1.0
  • a and B are heated to a temperature of 75 ° C. in separate storage containers.
  • Phases A and B / C are mixed intensively by pumping them through a micromixer heated to 75 ° C.
  • the resulting emulsion is collected in a storage vessel.
  • D is added after cooling to a temperature below 35 ° C.
  • Viscosity 43,000 mPa.s (Brookfield LVT T-bar spindle, E, rpm 6, 1 min.)
  • the mixture obtained is homogenized for a further 5 minutes.
  • composition specified under B is heated to a temperature of 80 ° C. with the exception of Keltrol. Keltrol is dispersed with stirring at constant temperature in the submitted composition.
  • compositions A and B are mixed in a micromixer as described above.
  • Viscosity 16,000 mPa.s (Brookfield LVT, T-) spindle D, rpm 6, min.)

Abstract

The present invention relates to a method for producing cosmetic or pharmaceutical formulations directly before use. Two or more liquid components from separate storage chambers are intimately mixed together by feeding the liquid components through a micromixer. The invention also relates to the lotions, emulsions, gels, cremes and solutions for cosmetic use or, provided that corresponding pharmaceutical active substances are incorporated, for the produced pharmaceutical formulations, whereby the lotions, emulsions, gels, cremes and solutions are produced by the inventive method.

Description

VERFAHREN ZUR HERSTELLUNG VON KOSMEΗSCHEN ODER PHARMAZEUTISCHEN FORMULIERUNGEN DURCH MIKROMISCHUNG UNMITTELBAR VOR DER VERWENDUNGMETHOD FOR PRODUCING COSMIC OR PHARMACEUTICAL FORMULATIONS BY MICROMIXING DIRECTLY BEFORE USE
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von kosmetischen oder pharmazeutischen Formulierungen unmittelbar vor der Verwendung, wobei zwei oder mehrere flüssige Komponenten aus getrennten Vorratskammern miteinander innig vermischt werden, indem die flüssigen Komponenten durch einen Mikromischer geführt werden. Wei- terhin betrifft die vorliegende Erfindung auch die durch das erfindungsge- mäße Verfahren hergestellten Lotionen, Emulsionen, Gele, Cremes und Lösungen entweder für die kosmetische Anwendung oder, sofern entsprechende pharmazeutische Wirkstoffe eingearbeitet sind, die hergestellten pharmazeutische Formulierungen.The present invention relates to a method for producing cosmetic or pharmaceutical formulations immediately before use, two or more liquid components from separate storage chambers being intimately mixed with one another by passing the liquid components through a micromixer. Furthermore, the present invention also relates to the lotions, emulsions, gels, creams and solutions produced by the process according to the invention, either for cosmetic use or, if appropriate pharmaceutical active ingredients have been incorporated, the pharmaceutical formulations prepared.
Zur Herstellung kosmetischer Produkte werden verschiedene Verfahren angewendet, mehrere Stoffe möglichst innigst zu vermischen. Je nach der erforderlichen Mischintensität werden ein oder mehrere Verfahren der Stoffvereinigung eingesetzt, die nacheinander oder parallel ablaufen können.Various processes are used to manufacture cosmetic products, to mix several substances as intimately as possible. Depending on the required mixing intensity, one or more methods of combining substances are used, which can take place in succession or in parallel.
An sich sind in der chemischen Verfahrenstechnik unter Mischen Grundoperationen zu verstehen, die der weitestgehenden Homogenisierung von Stoffen dienen. Es sollen Stoffströme so vereinigt werden, daß in Teilvolumina der entstehenden Mischung eine möglichst gleichmäßige Zusam- mensetzung der einzelnen Komponenten gegeben ist.In chemical process engineering, mixing is to be understood as basic operations which serve the greatest possible homogenization of substances. Material flows should be combined in such a way that the individual components are composed as evenly as possible in partial volumes of the resulting mixture.
Eine Spezialform des Mischens stellt das Homogenisieren dar. Hierunter ist ein Vermischen von an sich nicht ineinander mischbaren Phasen zu verstehen. Unter Homogenisieren versteht man demnach ein Verändern des Verteilungszustands und der Teilchengröße der inneren Phase von Emulsionen und Suspensionen, so daß mikroskopisch betrachtet ein homogenes System entsteht und sich die verteilte Phase ohne Einwirkung äußerer Kräfte nicht absetzt oder aufrahmt.Homogenization is a special form of mixing. This is understood to mean mixing phases that are not miscible with one another. Homogenization is understood to mean changing the distribution state and particle size of the inner phase of emulsions and suspensions, so that microscopically, a homogeneous system is created and the distributed phase does not settle or cream without the action of external forces.
Unter Dispergieren ist ein Vermischen eines aus zwei (oder mehreren) Phasen bestehenden Stoffsystems zu verstehen, bei dem ein Stoff (disperse Phasen) in einem anderen (Dispersionsmittel) in feinster Form ver- teilt (dispergiert) wird. Sowohl die Teilchen der dispersen Phase als auch das Dispersionsmittel können fest, flüssig oder gasförmig sein. Beispiele für Dispersionen sind Aerosole, Emulsionen, Suspensionen und Kolloide.Dispersing is understood to mean a mixing of a material system consisting of two (or more) phases, in which one substance (disperse phases) is mixed in another (dispersion medium) in the finest form. divides (disperses). Both the particles of the disperse phase and the dispersant can be solid, liquid or gaseous. Examples of dispersions are aerosols, emulsions, suspensions and colloids.
Eine andere in der Kosmetikherstellung übliche Art des Vermischens besteht im Emulgieren. Darunter ist ein Vermischen von zwei nicht oder nur wenig ineinander löslichen Flüssigkeiten zu verstehen, von denen die eine in der anderen fein verteilt wird. Die äußere Phase bezeichnet man als die kontinuierliche Phase bzw. als Dispersionsmittel, die darin verteilte Flüssigkeit als die innere, diskontinuierliche oder disperse Phase. Kosmetische Emulsionen bestehen meistens aus einer wäßrigen polaren Phase und einer unpolaren Ölphase.Another type of mixing that is common in cosmetics production is emulsification. This is understood to mean mixing two liquids which are insoluble or only slightly soluble in one another, one of which is finely distributed in the other. The outer phase is referred to as the continuous phase or as a dispersant, the liquid distributed therein as the inner, discontinuous or disperse phase. Cosmetic emulsions mostly consist of an aqueous polar phase and a non-polar oil phase.
Unter Suspendieren wiederum ist das Verteilen sehr kleiner, jedoch nicht molekularer Teilchen eines festen Stoffes in einer Flüssigkeit zu verstehen. Suspensionen sind wie Emulsionen meist optisch trüb und neigen dazu, sich unter Einfluß der Schwerkraft abzusetzen.Suspending in turn means the distribution of very small, but not molecular, particles of a solid in a liquid. Suspensions, like emulsions, are usually optically cloudy and tend to settle under the influence of gravity.
Emulgierprozesse erfolgen üblicherweise nach folgendem Schema: Es werden zwei ineinander unlösliche Stoffe, nämlich Fett und Wasser, ver- mischt. Um eine haltbaren Emulsion zu erhalten, müssen Fett- und Wasserphase mechanisch unter 10 μm zerkleinert und anschließend mit Hilfe eines Emulgators stabilisiert werden. Normalerweise werden Öl- und Fettphase getrennt vorgelegt, auf 50 - 70 °C erwärmt und anschließend voremulgiert. Alle wasserlöslichen Stoffe befinden sich dabei in der Was- serphase, alle fettlöslichen in der Fettphase.Emulsification processes are usually carried out according to the following scheme: Two substances that are insoluble in each other, namely fat and water, are mixed. In order to obtain a durable emulsion, the fat and water phases have to be mechanically crushed to below 10 μm and then stabilized with the help of an emulsifier. Normally, the oil and fat phases are introduced separately, heated to 50 - 70 ° C and then pre-emulsified. All water-soluble substances are in the water phase, all fat-soluble substances in the fat phase.
Die nach dem Hot/Hot-Prozeß (beide Phasen werden getrennt auf 50- 70°C erwärmt) hergestellte Voremulsion wird vor der Zugabe von Parfümöl und Farbstoff bis auf Zimmertemperatur abgekühlt und anschlie- ßend nachemulgiert.The pre-emulsion produced after the hot / hot process (both phases are heated separately to 50-70 ° C) is cooled to room temperature before the addition of perfume oil and dye and then emulsified.
In einigen Fällen der Emulsionsherstellung kann von einer 20 - 30 °C warmen Wasserphase ausgegangen werden. Bei diesem Hot/Cold- Prozeß kann auf kühlen vor der Parfümöl- und Farbstoff zu gäbe verzichtet werden. Handelt es sich bei der Fettphase um ein bei Zimmertemperatur dünnflüssiges Öl, so können beide Phasen mit einer Temperatur von 20-30°C vorgelegt und emulgiert werden (Cold/Cold-Prozeß). (aus: W. Umbach, "Kosmetik", Georg Thieme Verlag, Stuttgart 1995)In some cases of emulsion production, a water phase at 20-30 ° C can be assumed. In this hot / cold process, there is no need to cool before the perfume oil and dye are added. If the fat phase is a thin oil at room temperature, both phases can be at a temperature of 20-30 ° C submitted and emulsified (cold / cold process). (from: W. Umbach, "Cosmetics", Georg Thieme Verlag, Stuttgart 1995)
Bei der Herstellung von Emulsionen, Suspensionen und Dispersionen, die an den Endverbraucher abgegeben werden, ist es wünschenswert, über einen längeren Zeitraum stabile Produkte zu erhalten, die nicht zum Entmischen neigen und worin gleichzeitig die hinzugefügten Wirkstoffe ihre Aktivität beibehalten. Die Stabilität der Mischungen wird in herkömmlichen Produkten durch die Zugabe von Additiven, wie z. B. Emulgatoren, Tensi-In the manufacture of emulsions, suspensions and dispersions which are delivered to the end user, it is desirable to obtain stable products over a longer period of time which do not tend to separate and at the same time in which the added active ingredients retain their activity. The stability of the mixtures is in conventional products by the addition of additives such. B. emulsifiers, tensi
I Q den oder dergleichen erzielt. Um eine Zersetzung der Inhaltsstoffe zu verhindern und eine Abnahme der Aktivität von enthaltenen Wirkstoffen zu unterbinden, werden z. B. Oxidationsstabilisatoren, Radikalfänger, Bakterizide und andere Zusätze hinzugefügt. Verschiedene dieser Zusätze können bei empfindlichen Anwendern zu Reizungen oder AllergienI Q achieved the or the like. In order to prevent decomposition of the ingredients and to prevent a decrease in the activity of active ingredients contained, z. B. Added oxidation stabilizers, radical scavengers, bactericides and other additives. Various of these additives can cause irritation or allergies in sensitive users
15 führen. 15 lead.
Zur Stabilisierung von Wirkstoffen wird daher in vielen Fällen nicht der Wirkstoff selbst sondern eines seiner stabileren Derivate verwendet, welches sich dann am Wirkort zersetzt und den Wirkstoff freisetzt. Dieses ist natürlich mit dem Problem behaftet, daß bei gegebenenfalls vorgeschal-In many cases, therefore, it is not the active ingredient itself that is used to stabilize active ingredients, but one of its more stable derivatives, which then decomposes at the site of action and releases the active ingredient. This is of course fraught with the problem that if
20 teten erforderlichen Transport- oder Stoffwechselvorgängen das Derivat sich anders verhält als der eigentliche Wirkstoff.If necessary transport or metabolic processes occur, the derivative behaves differently than the actual active ingredient.
Ein weiteres Problem bei der Herstellung der oben aufgeführten Mischungen ist die homogene Vermischung der Einzelsubstanzen in jedem Volumenelement der gesamten Mischung.Another problem in the production of the mixtures listed above is the homogeneous mixing of the individual substances in each volume element of the entire mixture.
Zur Herstellung kosmetischer Formulierungen werden häufig einfache Rührgefäße mit verschiedenen Rührertypen verwendet. In den Rührgefäßen treten je nach Rührertyp (z.B. Anker-, Propeller-, Schrägblatt-, Scheiben-, EKATO-MIG-Rührer, EKATO-Mizerscheibe) abhängig vom Ort imSimple mixing vessels with different types of stirrers are often used to produce cosmetic formulations. Depending on the type of stirrer (e.g. anchor, propeller, inclined blade, disc, EKATO-MIG stirrer, EKATO-Mizer disc) in the mixing vessels depending on the location
30 Rührgefäß unterschiedliche Scherkräfte auf. Gleiches gilt für die Tempe- raturverteilung und den Energieeintrag in die Formulierung, so daß im Ansatzgefäß Scherkräfte, Temperatur und eingebrachte Energie nicht „gleichmäßig" verteilt sind und so der Aufbau der resultierende Formulierung nachteilig beeinflußt wird. Konkret heißt dieses, daß beispielsweise30 mixing vessel with different shear forces. The same applies to the temperature distribution and the energy input into the formulation, so that shear forces, temperature and introduced energy are not “evenly” distributed in the preparation vessel and so the structure of the resulting formulation is adversely affected. Specifically, this means that, for example
35 Emulsionen entstehen können, in denen die emulgierte Phase sehr unter- schiedliche Teilchengrößen aufweist, bzw. in einem hergestellten Produkt die Wirkstoffverteilung ungleichmäßig ist.35 emulsions can arise in which the emulsified phase is very has different particle sizes, or the active ingredient distribution in a manufactured product is uneven.
Aufgabe der vorliegenden Erfindung ist es daher, ein Verfahren zur Ver- fügung zu stellen, wodurch vermischte Produkte erhalten werden, die in der gesamten Mischung eine homogene Verteilung aller enthaltenen Komponenten und gleichzeitig eine homogene Verteilung der Teilchenoder Tröpfchengröße aufweisen. Weiterhin ist es Aufgabe der Erfindung ein Verfahren zur Herstellung von kosmetischen oder pharmazeutischen Formulierungen zur Verfügung zu stellen, wodurch die Verwendung von Emulgatoren, Tensiden, Stabilisatoren, Oxidationsstabilisatoren, Radikalfängern, Bakteriziden und anderen Zusätzen eingeschränkt werden kann, bzw. wodurch im Idealfall auf ihre Verwendung ganz verzichtet werden kann. Aufgabe der Erfindung ist es auch, ein Verfahren zur Verfü- gung zu stellen, wodurch kosmetische oder pharmazeutische Formulierungen erst unmittelbar vor ihrer Anwendung in sehr kleinen Mengen hergestellt werden können.It is therefore an object of the present invention to provide a process whereby mixed products are obtained which have a homogeneous distribution of all the components contained in the entire mixture and at the same time a homogeneous distribution of the particle or droplet size. Furthermore, it is an object of the invention to provide a process for the production of cosmetic or pharmaceutical formulations, as a result of which the use of emulsifiers, surfactants, stabilizers, oxidation stabilizers, radical scavengers, bactericides and other additives can be restricted, or ideally, to their use can be dispensed with entirely. It is also an object of the invention to provide a process by which cosmetic or pharmaceutical formulations can only be produced in very small quantities immediately before they are used.
Die Lösung der erfindungsgemäßen Aufgabe erfolgt durch ein Verfahren zur Herstellung von kosmetischen oder pharmazeutischen Formulierungen unmittelbar vor der Verwendung, dadurch gekennzeichnet, daß zwei oder mehrere flüssige Komponenten aus getrennten Vorratskammern miteinander vermischt werden, indem sie durch einen Mikromischer geführt werden.The object of the invention is achieved by a process for the production of cosmetic or pharmaceutical formulations immediately before use, characterized in that two or more liquid components from separate storage chambers are mixed with one another by being passed through a micromixer.
Zur Durchführung des erfindungsgemäßen Verfahrens können aus getrennten Vorratskammern zwei oder mehrere Komponenten, gegebenenfalls nach Erwärmen, in flüssiger Form zum Vermischen durch einen Mikromischer geführt werden.To carry out the method according to the invention, two or more components, optionally after heating, can be passed in liquid form for mixing through a micromixer from separate storage chambers.
Das Vermischen kann erfolgen, indem die Komponenten aus getrennten Vorratskammern, gegebenenfalls nach Erwärmen, in flüssiger Form durch einen temperierten Mikromischer geführt werden und falls erforderlich zum Erkalten nachgerührt werden.Mixing can be carried out by passing the components from separate storage chambers, if necessary after heating, in liquid form through a temperature-controlled micromixer and stirring them if necessary to cool them down.
Die Durchführung des Verfahrens zur Herstellung von kosmetischen oder pharmazeutischen Formulierungen in Form von Emulsionen unmittelbar vor der Verwendung kann erfolgen, indem eine oder mehrere flüssige Komponente(n) mit einem oder mehreren natürlichen, synthetischen oder semisynthetischen Öl(en) aus getrennten Vorratskammern durch einen Mikromischer geführt werden, wobei sie miteinander vermischt werden.The implementation of the process for the production of cosmetic or pharmaceutical formulations in the form of emulsions immediately Before use, one or more liquid component (s) with one or more natural, synthetic or semi-synthetic oil (s) can be passed from separate storage chambers through a micromixer, mixing them together.
Die Lösung der erfindungsgemäßen Aufgabe erfolgt auch durch ein Verfahren zur Herstellung von kosmetischen Formulierungen in Form von Emulsionen unmittelbar vor der Verwendung, dadurch gekennzeichnet, daß eine Fettphase, bestehend aus einem oder mehreren natürlichen, synthetischen oder semisynthetischen Öl(en) und einem oder mehreren bei Raumtemperatur festen Fett(en), in einer Vorratskammer durch Erwärmen verflüssigt wird, und diese flüssige Fettphase mit einer oder mehreren flüssige Komponente(n) und gegebenenfalls mit einer weiteren Öl- phase vermischt wird, indem sie durch einen Mikromischer geführt wer- den.The object of the invention is also achieved by a process for the production of cosmetic formulations in the form of emulsions immediately before use, characterized in that a fat phase consisting of one or more natural, synthetic or semisynthetic oil (s) and one or more of Fat (s) which are solid at room temperature are liquefied in a storage chamber by heating, and this liquid fat phase is mixed with one or more liquid component (s) and optionally with another oil phase by passing them through a micromixer.
In einer besonderen Ausgestaltung des erfindungsgemäßen Verfahrens werden die zu vermischenden Komponenten aus den Vorratskammern gepumpt und durch sich anschließende dünne Röhrchen, welche jeweils in einem Kanal eines Mikromischer enden, in den Mikromischer geleitet werden und aufgrund des durch das Pumpen sich aufbauenden Drucks durch die Kanäle des Mikromischers unter intensiver Vermischung und Bildung einer Emulsion gedrückt werden.In a special embodiment of the method according to the invention, the components to be mixed are pumped out of the storage chambers and are passed into the micromixer through subsequent thin tubes, which each end in a channel of a micromixer, and through the channels of the pump due to the pressure building up as a result of the pumping Micromixer are pressed with intensive mixing and formation of an emulsion.
Erfindungsgemäß ist es auch möglich, die zu vermischenden Komponenten aus unter Druck stehenden Vorratskammern durch sich anschließende dünne Röhrchen, welche jeweils in einem Kanal eines Mikromischer enden, zu fördern, die Komponenten in den Mikromischer zu leiten und durch die Kanäle des Mikromischers aufgrund des sich aufbauenden Drucks unter intensiver Vermischung und Bildung einer Emulsion zu drük- ken.According to the invention, it is also possible to convey the components to be mixed from pressurized storage chambers through subsequent thin tubes, which each end in a channel of a micromixer, to guide the components into the micromixer and through the channels of the micromixer due to the build-up Pressure with intensive mixing and formation of an emulsion.
Die Lösung der erfindungsgemäßen Aufgabe erfolgt weiterhin durch ein Verfahren zur Herstellung von liposomenhaltigen Formulierungen unmit- telbar vor der Verwendung, indem eine oder mehrere flüssige Komponente^) mit einer Komponente, welche liposomenbildende Inhaltsstoffe O 00/54735 - 6 - PCT/EPOO/01974The object of the invention is further achieved by a process for the preparation of liposome-containing formulations immediately before use, by one or more liquid component ^) with a component which contains liposome-forming ingredients O 00/54735 - 6 - PCT / EPOO / 01974
enthält, aus getrennten Vorratskammern miteinander vermischt werden, indem sie durch einen Mikromischer unter Bildung der gewünschten Lipo- somen geführt werden. Dieses kann erfolgen, nachdem eine oder mehrere der zu vermischenden Komponente(n) vor der Herstellung der Formulie- rung erwärmt worden ist (sind). Dieses Verfahren kann in der Weise durchgeführt werden, daß die zu vermischenden Komponenten aus den Vorratskammern gepumpt werden und durch sich anschließende dünne Röhrchen, welche jeweils in einem Kanal eines Mikromischer enden, in den Mikromischer geleitet werden und aufgrund des durch das Pumpen sich aufbauenden Drucks durch die Kanäle der Mikromischer unter intensiver Vermischung und Bildung einer liposomenhalfigen Formulierung gedrückt werden.contains, are mixed together from separate storage chambers by passing them through a micromixer to form the desired liposomes. This can take place after one or more of the component (s) to be mixed has been heated before the formulation is prepared. This method can be carried out in such a way that the components to be mixed are pumped out of the storage chambers and are passed into the micromixer through the subsequent thin tubes, which each end in a channel of a micromixer, and because of the pressure built up by the pumping the channels of the micromixers are pressed with intensive mixing and formation of a liposome-helpful formulation.
Insbesondere können die zu vermischenden Komponenten aus unter Druck stehenden Vorratskammern gefördert und durch sich anschließende dünne Röhrchen, welche jeweils in einem Kanal eines Mikromischer enden, in den Mikromischer geleitet werden. Aufgrund des aus den Vorratskammern herrührenden Drucks wird im Mikromischer ein ausreichender Druck aufgebaut, durch den die Komponenten durch die Kanäle unter intensiver Vermischung und Bildung einer liposomenhalfigen Formulierung gedrückt werden.In particular, the components to be mixed can be conveyed from pressurized storage chambers and passed into the micromixer through adjoining thin tubes, which each end in a channel of a micromixer. Due to the pressure coming from the storage chambers, a sufficient pressure is built up in the micromixer, by means of which the components are pressed through the channels with intensive mixing and formation of a liposome-helpful formulation.
Die Lösung der vorliegenden Aufgabe erfolgt auch durch Lotionen oder Lösung, Emulsionen, Gele und Cremes, welche durch das erfindungsge- mäße Verfahren hergestellt werden können.The present object is also achieved by means of lotions or solutions, emulsions, gels and creams which can be produced by the process according to the invention.
Für bestimmte Formulierungen ist die gleichmäßige Durchmischung, eine konstante Temperatur und ein gleichmäßiger Energieeintrag bereits im Mi- krobereich wichtig. Es wurde nun gefunden, daß durch den Einsatz von Mikromischem dieFor certain formulations, uniform mixing, a constant temperature and even energy input in the micro range is important. It has now been found that the use of micromixers
Herstellung von Mischungen in Form von Emulsionen, Suspensionen und Dispersionen, Lotionen, Lösungen Gelen und Cremes möglich ist, in denen alle Inhaltsstoffe auch in kleinsten Volumenteilen gleich verteilt sind. Im Gegensatz zu einem großvolumigen Rührkessel ist die Herstellung dieser Mischungen unter gleichmäßigen Temperaturbedingungen auch im Mikro- bereich möglich, da sich in den dünnen, gegebenenfalls laminatartigen Ka- nälen kein Temperaturgefälle ausbildet, insbesondere wenn der Mikromischer temperierbar ausgestaltet ist. Weiterhin ist der Energieeintrag in jedem, d. h. auch im kleinsten Volumenteil, gleich. Es wurde auch gefunden, daß Emulsionen mit einer wesentlich homogeneren Tröpfchengrößenver- teilung hergestellt werden können als in einem Rührgefäß. Aufgrund der multiplen Scherbedingungen der kommunizierenden Kanäle im Mikromischer werden zwangsläufig Tröpfchengrößen im Mikrobereich vorgegeben, so daß Mikroemulsionen erhalten werden, die in einem Rührgefäß nur sehr aufwendig hergestellt werden könnten. Die Verwendung eines Mikromi- schers eignet sich daher zur Herstellung sehr feiner homogener Formulierungen.Production of mixtures in the form of emulsions, suspensions and dispersions, lotions, solutions, gels and creams is possible, in which all ingredients are evenly distributed in the smallest parts by volume. In contrast to a large-volume stirred kettle, these mixtures can also be produced in the micro range under uniform temperature conditions, since the thin, possibly laminate-like no temperature drop forms, especially if the micromixer is designed for temperature control. Furthermore, the energy input is the same in every, ie even in the smallest part of the volume. It has also been found that emulsions can be produced with a much more homogeneous droplet size distribution than in a stirred vessel. Due to the multiple shear conditions of the communicating channels in the micromixer, droplet sizes in the micro range are inevitable, so that microemulsions are obtained which could only be produced in a stirred vessel in a very complex manner. The use of a micromixer is therefore suitable for the production of very fine, homogeneous formulations.
Zur Durchführung des erfindungsgemäßen Verfahrens sind Mikromischer, dazugehörende An- und Verschlußsysteme geeignet, die in den Patentan- meidungen DE 1 95 11 603, DE 1 97 46 583, DE 1 97 46 584,Micromixers, associated connection and closure systems are suitable for carrying out the method according to the invention, which are described in patent applications DE 1 95 11 603, DE 1 97 46 583, DE 1 97 46 584,
DE 19746585 und DE 1 98 54 096 beschrieben sind, sowie dem sich Fachmann sich daraus ergebenden Ausgestaltungen. Geeignete Mikromischer können aus geeigneten metallischen, keramischen, polymeren Werkstoffen oder aus Silicium bestehen.DE 19746585 and DE 1 98 54 096 are described, as well as the embodiments resulting therefrom. Suitable micromixers can consist of suitable metallic, ceramic, polymeric materials or silicon.
Problematische Formulierungen sind im W/O-Bereich Emulsionen insbesondere solche mit hohen Gehalten an pflanzlichen Triglyceriden. Emulsionen ohne stabilisierende Wachse zeichnen sich häufig durch ungenügende Langzeitviskositätskonstanz aus und O W-Lotionen sind generell schwieriger zu stabilisieren als Cremes. Diese Emulsionen lassen sich daher besonders gut herstellen unter Verwendung von Mikromischem. Von besonderem Vorteil ist hierbei, daß durch Verwendung von Mikromischem besonders geringe Mengen hergestellt werden können, die vorteilhafter Weise in situ, d. h. direkt vor der Verwendung hergestellt werden können.Problematic formulations in the W / O field are emulsions, in particular those with high levels of vegetable triglycerides. Emulsions without stabilizing waxes are often characterized by insufficient long-term viscosity constancy and OW lotions are generally more difficult to stabilize than creams. These emulsions can therefore be produced particularly well using micromixers. It is particularly advantageous here that particularly small quantities can be produced by using micromixers, which advantageously in situ, i. H. can be made directly before use.
Mikroemulsionen sind dann thermodynamisch stabil, wenn sie aufgrund extrem geringer Grenzflächenenergie spontan entstehen, das heißt, ohne Zufuhr von äußerer mechanischer Energie. Die Tröpfchendurchmesser sind wesentlich geringer als bei Makroemulsionen, sie liegen im Bereich von 10-30 nm (Nanometer), das bedeutet unterhalb der Wellenlänge des sichtbaren Lichtes. Mikroemulsionen sind daher kolloid-disperse, optisch transparente Systeme. Nach POHLER sind zur Formulierung von Mikroemulsionen bestimmte Konzentrationsbereiche der Öl- und der Wasserphase sowie der Emulgatoren und Hilfsstoffe einzuhalten:Microemulsions are thermodynamically stable if they arise spontaneously due to extremely low interfacial energy, that is, without the addition of external mechanical energy. The droplet diameters are much smaller than with macroemulsions, they are in the range of 10-30 nm (nanometers), which means below the wavelength of visible light. Microemulsions are therefore colloidally disperse, optical transparent systems. According to POHLER, certain concentration ranges of the oil and water phases as well as the emulsifiers and auxiliary substances must be observed when formulating microemulsions:
Tenside (meist Niotenside) 15 - 40%Surfactants (mostly non-ionic surfactants) 15 - 40%
Mineralöl bzw. Pflanzenöl 5 - 25%Mineral oil or vegetable oil 5 - 25%
Polyalkohole 0 - 20%Polyalcohols 0 - 20%
Wasser 35 - 65%Water 35 - 65%
Durch den Einsatz von Mikromischern zur Herstellung von Mikroemulsionen ist es möglich, den Einsatz von Tensiden erheblich zu reduzieren, so daß die Verträglichkeit für besonders empfindliche Hauttypen wesentlich erhöht werden kann. Stabile Mikroemulsionen lassen sich bereits bei Verwendung von weniger als 10 Gew.-% Tensiden herstellen.The use of micromixers for the production of microemulsions makes it possible to considerably reduce the use of surfactants, so that the tolerance for particularly sensitive skin types can be significantly increased. Stable microemulsions can be produced using less than 10% by weight of surfactants.
Üblicherweise sind die wichtigsten Anforderungen an Emulgiergeräte ausreichende und insbesondere variable Emulgierleistung, genügend Scherbzw. Schlag- und Prallkräfte, Ausstattung für eine gleichmäßige Bearbei- tung des Ansatzes, Vakuumvorrichtung, Heizung und Kühlung (14). Diese Probleme lassen sich erfindungsgemäß in einfacher Weise durch den Einsatz von geeigneten Mikromischern lösen, die einen gezielten Ener- gieeintrg in jedem Volumenelement gewährleisten und in denen unter Einwirkung intensiver Scherkräfte in den dünnen Kanälen eine intensive Vermischung stattfindet.Usually, the most important requirements for emulsifying devices are sufficient and in particular variable emulsifying performance, sufficient shear or. Impact and impact forces, equipment for uniform processing of the attachment, vacuum device, heating and cooling (14). According to the invention, these problems can be solved in a simple manner by using suitable micromixers which ensure targeted energy input in each volume element and in which intensive mixing takes place in the thin channels under the action of intensive shear forces.
Weiterhin ist es durch die Verwendung von Mikromischern möglich, sehr kleine Mengen der gewünschten kosmetischen oder pharmazeutischen Formulierungen unmittelbar vor der Verwendung herzustellen. Dieses hat den Vorteil, daß der Zusatz von Emulgatoren, Suspensions- und Dispersionshilfen in Form von Tensiden und anderen Additiven wie z. B. Stabilisatoren sehr eingeschränkt werden kann bzw. auf ihre Verwendung ganz verzichtet werden kann. Es ist auf diese Weise auch möglich, über längere Zeit nicht miteinander in einer Formulierung verträgliche Wirkstoffe oder Zusätze erst direkt vor der Verwendung miteinander zu vermischen. Wirkstoffe, die in einer Formulierung nur in Form eines Derivats stabil sind, können als solche in einer getrennten Formulierung vorgelegt werden und erst direkt vor der Verwendung der übrigen Mischung zugefügt werden. Auch können so vom Anwender je nach Wunsch zu kleinen Mengen einer Basismischung zu unterschiedlichen Zeitpunkten verschiedene Zusätze zugefügt werden. Dieses kann sowohl für pharmazeutische als auch für kosmetische Formulierungen von Interesse sein, wenn zu verschiedenen Zeitpunkten unterschiedliche Wirkstoffe appliziert werden sollen.Furthermore, the use of micromixers makes it possible to produce very small amounts of the desired cosmetic or pharmaceutical formulations immediately before use. This has the advantage that the addition of emulsifiers, suspension and dispersion aids in the form of surfactants and other additives such as. B. stabilizers can be very limited or their use can be omitted entirely. In this way it is also possible to mix active ingredients or additives which are not compatible with one another in a formulation for a long time only immediately before use. Active ingredients that are only stable in the form of a derivative in a formulation, can be presented as such in a separate formulation and added directly before the rest of the mixture is used. The user can also add different additives to small quantities of a base mixture at different times, as required. This can be of interest for both pharmaceutical and cosmetic formulations if different active ingredients are to be applied at different times.
Zu einer kosmetischen Basisformulierung können für den Tag andere Zu- sätze hinzugefügt werden als für die Nacht. Zusätze für den Tag können beispielsweise UV-Filter sein, für die Nacht dagegen regenerierende Zusätze.Other additives can be added to a basic cosmetic formulation for the day than for the night. Additives for the day can be UV filters, for example, while regenerative additives for the night.
Zur Veranschaulichung und zum besseren Verständnis der vorliegenden Erfindung werden im folgenden Beispiele gegeben. Diese sind jedoch aufgrund der allgemeinen Gültigkeit des beschriebenen Erfindungsprinzips nicht geeignet, den Schutzbereich der vorliegenden Anmeldung nur auf diese Beispiele zu reduzieren. Weiterhin ist der Inhalt der zitierten Patentanmeldungen als Teil der Offenbarung der vorliegenden Erfindung der vorliegenden Beschreibung anzusehen.Examples are given below to illustrate and better understand the present invention. However, due to the general validity of the principle of the invention described, these are not suitable for reducing the scope of protection of the present application only to these examples. Furthermore, the content of the cited patent applications is to be regarded as part of the disclosure of the present invention and the present description.
Beispiel 1example 1
Hand & Nagel CremeHand and nail cream
Rohstoff INCI % W/WRaw material INCI% W / W
A Paraffin (1) Mineral Oil 2,00A Paraffin (1) Mineral Oil 2.00
(Art-Nr. 107162)(Item no.107162)
Arlamol HD (2) Isohexadecane 2,00Arlamol HD (2) isohexadecane 2.00
Isopropylpalmitat (3) Isopropyl Palmitate 3,00Isopropyl palmitate (3) Isopropyl palmitate 3.00
Sojaöl (4) Glycine Soja 0,50Soybean Oil (4) Glycine Soybean 0.50
Mirasil DM 350 (5) Dimethicone 1 ,00Mirasil DM 350 (5) Dimethicone 1, 00
La nette O (3) Cetearyl Alcohol 1 ,00La nice O (3) Cetearyl Alcohol 1.00
Span 60 (2) Sorbitan Stearate 1 ,50Span 60 (2) Sorbitan Stearate 1, 50
Montanov 68 (6) Cetearyl Alcohol (and) Cetearyl Glucoside 4,00Montanov 68 (6) Cetearyl Alcohol (and) Cetearyl Glucoside 4.00
(-) -(α-Bisabolol (1 ) Bisabolol 0,30(-) - (α-bisabolol (1) bisabolol 0.30
(Art.-Nr.130170) B Demin. Wasser Aqua ad 100(Art.No. 130170) B Demin. Water aqua ad 100
Glycerin, 87% ig (D Glycerin 10,00Glycerin, 87% (D glycerin 10.00
(Art-Nr.104091)(Item no.104091)
D-Panthenol (7) Panthenol 0,50D-panthenol (7) panthenol 0.50
(D+)-Biotin d) Biotin 0,05(D +) - biotin d) biotin 0.05
(Art-Nr.130220)(Item no.130220)
(gegebenenfalls) Konservierungsmittel q.s.(if necessary) preservatives q.s.
C Rhodicare S (5) Xanthan Gum 0,30C Rhodicare S (5) xanthan gum 0.30
Gegebenenfalls:Possibly:
D Parfüm Bianca (8) Parfüm 0,20D Bianca perfume (8) 0.20 perfume
Herstellung:Manufacturing:
Die Phasen A, B und C werden jeweils getrennt in einem Vorratsbehälter vorgelegt und auf 75°C erhitzt. Die somit flüssigen Phasen B und C werden aus den Vorratsbehältern gepumpt und durch einen auf 75 °C temperierten Mikromischer geführt und vermischt. Die aus dem Mikromischer austretende Mischung wird anschließend mit Phase A durch einen auf 75 °C temperierten Mi- kromischer gepumpt und homogenisiert. Die erhaltene Emulsion wird in einemPhases A, B and C are each placed separately in a storage container and heated to 75 ° C. The thus liquid phases B and C are pumped out of the storage containers and passed through a micromixer heated to 75 ° C. and mixed. The mixture emerging from the micromixer is then pumped with phase A through a micromixer heated to 75 ° C. and homogenized. The emulsion obtained is in a
Vorratsbehälter gesammelt und unter Rühren abgekühlt. Bei einer Temperatur von ca. 35°C kann gegebenenfalls das Parfüm zugegeben werden.Storage container collected and cooled with stirring. At a temperature of approx. 35 ° C the perfume can be added if necessary.
Bemerkungen:Remarks:
PH25°c -Wert: 5,5 P H 25 ° C value: 5.5
Viskosität: 43000 mPa.s (Brookfield RVT, Spindel C, 5 upm, Helipath) bei 25°C 0,05% Propyl-4-hydroxybenzoat (Merck KGaA, Art-Nr. 130173), 0, 15% Methyl-4-hydroxybenzoat (Merck KGaA, Art-Nr. 13 0174), 0,30% Germall 115 (ISP, Frechen)Viscosity: 43000 mPa.s (Brookfield RVT, spindle C, 5 rpm, Helipath) at 25 ° C 0.05% propyl 4-hydroxybenzoate (Merck KGaA, item no.130173), 0.15% methyl 4- hydroxybenzoate (Merck KGaA, Art. No. 13 0174), 0.30% Germall 115 (ISP, Frechen)
Bezugsquellen:Sources of supply:
(1) Merck KGaA, Darmstadt(1) Merck KGaA, Darmstadt
(2) ICI Surfactants, Essen(2) ICI Surfactants, Essen
(3) Henkel KGaA, Düsseldorf(3) Henkel KGaA, Düsseldorf
(4) Gustav Hees, Stuttgart(4) Gustav Hees, Stuttgart
(5) Rhodia, Frankfurt (6) Seppic, Frankreich(5) Rhodia, Frankfurt (6) Seppic, France
(7) BASF, Ludwigshafen(7) BASF, Ludwigshafen
(8) H&R, Holzminden (8) H&R, Holzminden
Beispiel 2Example 2
W/0 Körperpflegemilch (KALT-HEI STELLUNW / 0 body care milk (KALT-HEI STELLUN
A. ARLACEL 780 5.0 %A. ARLACEL 780 5.0%
Paraffinöl dünnflüssig 10.0 %Paraffin oil thin 10.0%
Miglyol 812 4.0 %Miglyol 812 4.0%
ARLAMOL HD 5 0 %ARLAMOL HD 5 0%
ARLAMOL E 1.0 %ARLAMOL E 1.0%
Parfüm (evtl.) q.s.Perfume (possibly) q.s.
B. Glycerin 2.5 %B. Glycerin 2.5%
ATLAS G-2330 1.5 %ATLAS G-2330 1.5%
Mg S04 0.5 %Mg S0 4 0.5%
Demin. Wasser 70.5 %Demin. Water 70.5%
Konservierung (evtl.) q.s.Preservation (possibly) q.s.
Herstellunαsmethode:Manufacturing method:
Beide Phasen A und B werden jeweils getrennt in einem Vorratsbehälter vorgelegt. Nach dem Durchmischen, was entweder durch Rühren oder in kleinen Gefäßen durch Schütteln erfolgen kann, werden die Phasen aus den Vorratsbehältern gepumpt und gemeinsam durch einen Mikromischer geführt, worin die Phasen intensiv vermischt werden. Die homogen vermischte Milch kann direkt verwendet werden.Both phases A and B are placed separately in a storage container. After mixing, which can be done either by stirring or by shaking in small vessels, the phases are pumped out of the storage containers and passed together through a micromixer, in which the phases are mixed intensively. The homogeneously mixed milk can be used directly.
Viskosität:Viscosity:
10 000 mPa s (Brookfield LVT Helipath, Spindel C, 6 upm, 1 Min.)10,000 mPa s (Brookfield LVT Helipath, spindle C, 6 rpm, 1 min.)
Bezugsquellen:Sources of supply:
(1 ) ICI Surfactants(1) ICI surfactants
Beispiel 3Example 3
Sonnenschutzmilch (W/S) (Wasser in Silikon) A Eusolex 2292 (Art.-Nr. 5382) (D 2,00Sun protection milk (W / S) (water in silicone) A Eusolex 2292 (Art.No. 5382) (D 2.00
DC 1401 (2) 10,00DC 1401 (2) 10.00
DC 3225 C (2) 10,00DC 3225 C (2) 10.00
Dow Coming 344 (2) 10,00 q.s.Dow Coming 344 (2) 10.00 q.s.
B Eusolex 232 (Art.-Nr. 5372) (1 ) 2,00B Eusolex 232 (Item No. 5372) (1) 2.00
Tris(hydroxymethyl)- (1 ) 0,88 aminomethan (Art.-Nr. 8386)Tris (hydroxymethyl) - (1) 0.88 aminomethane (Item No. 8386)
Natriumchlorid (Art.-Nr. 6400) (1 ) 2,00Sodium chloride (Item No. 6400) (1) 2.00
Glycerin (Art.-Nr. 4093) (1 ) 5,00Glycerin (Item No. 4093) (1) 5.00
Konservierungsmittel (evtl.) q.s.Preservatives (possibly) q.s.
Wasser, demineralisiert ad 100,00Water, demineralized ad 100.00
Herstellung:Manufacturing:
In einem Vorratsgefäß wird zur Herstellung der Phase B Tris(hydroxymethyl)-aminomethan zur Neutralisierung von Eusolex 232 in Wasser gelöst und Eusolex 232 zugegeben. Nach vollständiger Lö- sung werden die restlichen Rohstoffe der Phase B zugegeben. In einem zweiten Vorratsgefäß werden die Komponenten Phase A vorgemischt.To produce phase B, tris (hydroxymethyl) aminomethane is dissolved in water in a storage vessel to neutralize Eusolex 232 and Eusolex 232 is added. After the solution has been completely dissolved, the remaining phase B raw materials are added. The components of phase A are premixed in a second storage vessel.
Zur Herstellung der Sonnenschutzmilch werden die beiden Phasen zum Vermischen gemeinsam mit Hilfe einer Pumpe durch einen über dünne Anschlußröhrchen angeschlossenen Mikromischer gepumpt.To produce the sun protection milk, the two mixing phases are pumped together with the help of a pump through a micromixer connected via thin connecting tubes.
BemerkungenRemarks
Viskosität 22.800 mPas (Brookfield RVT, Sp. C, 10 Upm) bei 25 'C Muster enthalten als Konservierungsmittel 0,05 % Propyl-4-hydroxybenzoat (Merck Art.-Nr. 7427)Viscosity 22,800 mPas (Brookfield RVT, Sp. C, 10 rpm) at 25 'C samples contain 0.05% propyl 4-hydroxybenzoate as a preservative (Merck item no. 7427)
0, 17 % Methyl-4-hydroxybenzoat Natriumsalz (Merck Art.-Nr. 6756)0.17% methyl 4-hydroxybenzoate sodium salt (Merck Art.No. 6756)
Bezugsguellen:Reference sources:
(1 ) E. Merck, Darmstadt(1) E. Merck, Darmstadt
(2) Dow Corning, Düsseldorf Beispiel 4(2) Dow Corning, Düsseldorf Example 4
Transparente MikroemulsionTransparent microemulsion
Handelsname INCI Gew.-%Trade name INCI% by weight
Eumulgin B2 Ceteareth-20 19,5Eumulgin B2 Ceteareth-20 19.5
Cetiol RE PEG-7 Glyceryl Cocoate 20.0Cetiol RE PEG-7 Glyceryl Cocoate 20.0
Uniphen P-23 Phenoxyethanol + Methyl-/Uniphen P-23 phenoxyethanol + methyl- /
Ethyl-/Propyl-/Butylparaben 0.3Ethyl / propyl / butyl paraben 0.3
Mineralöl Mineral Oil 5.0Mineral oil 5.0
Glycerin Glycerin 20.0Glycerin Glycerin 20.0
Wasser, demin. Water 35.2Water, demin. Water 35.2
Herstellung:Manufacturing:
1. Eumulgin B2, Cetiol HE, Uniphen P-23 und das Paraffinöl werden in einem Vorratsgefäß vorgelegt, unter Durchmischen geschmolzen und auf ca. 95°C-105°C erhitzt.1. Eumulgin B2, Cetiol HE, Uniphen P-23 and the paraffin oil are placed in a storage vessel, melted while mixing and heated to approx. 95 ° C-105 ° C.
2. Wasser und das Glycerin werden zusammengegeben und ebenfalls auf ca. 95°C-100°C erwärmt. Die Wassermenge um 3% erhöhen.2. Water and the glycerin are combined and also heated to approx. 95 ° C-100 ° C. Increase the amount of water by 3%.
3. Die Wasserphase und die Fettphase werden zur intensiven Durchmischung durch einen Mikromischer gepumpt. Das entstandene Mikroemulsionsgel zum Erkalten gerührt.3. The water phase and the fat phase are pumped through a micromixer for intensive mixing. The resulting microemulsion gel was stirred to cool.
Alternativ ist es möglich, das Mikroemulsionsgel durch einen weiteren gekühlten Mikromischer zu führen, dessen auslaufenden Kanäle einen weiteren Querschnitt aufweisen, wodurch ein Verstopfen der Kanäle vermieden wird und die Bildung von Lufteinschlüssen im Gel unterbunden werden.Alternatively, it is possible to pass the microemulsion gel through a further cooled micromixer, the outgoing channels of which have a further cross section, as a result of which the channels are not clogged and the formation of air pockets in the gel is prevented.
Bei einer Temperatur, bei der das Mikroemulsionsgel eben noch gießfähig ist, wird es in das Primärpackmittel abgefüllt. Beispiel 5At a temperature at which the microemulsion gel is just pourable, it is filled into the primary packaging. Example 5
Sonnenschutzgel (Emulgator-frei)Sun protection gel (emulsifier-free)
SPF 3,21 UVA PF 2.5 (Sun protection factor, Diffey Methode)SPF 3.21 UVA PF 2.5 (Sun protection factor, Diffey method)
Gew.-%% By weight
A Eusolex 2292 (Art.-Nr. 105382) (1 ) 1 ,000A Eusolex 2292 (Art.No. 105382) (1) 1,000
Luvitol EHO (2) 9,000Luvitol EHO (2) 9,000
Dow Corning 200 (100 es) (3) 2,000 Antaron V-220 (4) 2,000Dow Corning 200 (100 es) (3) 2,000 Antaron V-220 (4) 2,000
Jojobaöl (5) 5,000Jojoba Oil (5) 5,000
DL-α-Tocopherolacetat (1 ) 0,500 (Art. Nr. 500952)DL-α-tocopherol acetate (1) 0.500 (Art. No. 500952)
B Tris(hydroxymethyl)-aminomethan (1 ) 0,700B tris (hydroxymethyl) aminomethane (1) 0.700
(Art.-Nr. 108386) Wasser, demineralisiert 14,300(Art.no.108386) Water, demineralized 14.300
C Pemulen TR-1 (6) 0,600C Pemulen TR-1 (6) 0.600
Konservierungsmittel (evtl.) (1 ) q.s.Preservative (possibly) (1) q.s.
Wasser, demineralisiert ad 100, 000Water, demineralized ad 100, 000
D Aloe Vera Gel 1 : 10 (7) 1 ,000D Aloe Vera Gel 1:10 (7) 1,000
Herstellung:Manufacturing:
Für Phase C das Pemulen TR-1 im Wasser homogen dispergieren, Konservierungsmittel hinzufügen und vorquellen. Phase B unter Homogenisieren in Phase C eintragen. Phase A unter Erhitzen lösen und langsam unter Homogenisieren zugeben. Bei 35°C Phase D zusetzen und nochmals homogenisieren.For phase C, disperse the Pemulen TR-1 homogeneously in the water, add the preservative and swell. Enter phase B under homogenization in phase C. Dissolve phase A while heating and add slowly while homogenizing. Add phase D at 35 ° C and homogenize again.
Bemerkungen:Remarks:
Viskosität 67.000 mPas (Brookfield RVT, Sp. C, 5 Upm) bei 25°CViscosity 67,000 mPas (Brookfield RVT, Sp. C, 5 rpm) at 25 ° C
PH25°C = 6,9 Als Konservierungsmittel kann 1 ,0 % Phenoxyethanol (Merck-Art.-Nr. 807291 ) hinzugefügt werden. BezugsguellenPH 25 ° C = 6.9 As a preservative, 1.0% phenoxyethanol (Merck item no. 807291) can be added. Reference sources
(1 ) Merck KGaA, Darmstadt (2) BASF, Ludwigshafen(1) Merck KGaA, Darmstadt (2) BASF, Ludwigshafen
(3) Dow Corning, Düsseldorf (4) GAF, Frechen(3) Dow Corning, Düsseldorf (4) GAF, Frechen
(5) Henry Lamotte, Bremen (6) Goodrich, Neuss(5) Henry Lamotte, Bremen (6) Goodrich, Neuss
(7) Rahn, Maintal(7) Rahn, Maintal
Beispiel 6Example 6
In situ W/O/W super moisturising creamIn situ W / O / W super moisturizing cream
Zusammensetzung:Composition:
W/WW / W
'Brij 721 2.0'Brij 721 2.0
Brij 72 3.0Brij 72 3.0
Arlacel P135 0.5Arlacel P135 0.5
Arlamol E 5.0Arlamol E 5.0
Arlamol HD 4.0Arlamol HD 4.0
Vitamin E Acetat 1.0Vitamin E acetate 1.0
Laurex CS 1.0Laurex CS 1.0
Stearinsäure 1.5Stearic acid 1.5
Mirasil DM 100 1 ,0Mirasil DM 100 1.0
BB
1 ,2-Propylenglykol 4.01, 2-propylene glycol 4.0
Allantoin 0,2Allantoin 0.2
Harnstoff 0.5Urea 0.5
Wasser 74.4Water 74.4
Germaben II 1.0Germaben II 1.0
D. (gegebenenfalls) Parfüm L94-5770 0.1D. (if applicable) Perfume L94-5770 0.1
Herstellung:Manufacturing:
1. In getrennten Vorratsbehältern werden A und B auf eine Temperatur von 75°C erwärmt.1. A and B are heated to a temperature of 75 ° C. in separate storage containers.
2. Bevor die Emulsion hergestellt wird, wird C zu B hinzugefügt.2. Before the emulsion is made, C is added to B.
3. Die Phasen A und B/C werden intensiv vermischt, indem sie durch ei- nen auf 75 °C temperierten Mikromischer gepumpt werden.3. Phases A and B / C are mixed intensively by pumping them through a micromixer heated to 75 ° C.
4. Die entstandene Emulsion wird in einem Vorratsgefäß gesammelt.4. The resulting emulsion is collected in a storage vessel.
5. Gegebenenfalls wird nach dem Abkühlen auf eine Temperatur unterhalb von 35°C D hinzugefügt.5. If necessary, D is added after cooling to a temperature below 35 ° C.
6. Weiteres Abkühlen auf Raumtemperatur erfolgt unter leichtem Rühren.6. Further cooling to room temperature is carried out with gentle stirring.
Bemerkungen:Remarks:
Viskosität 43.000 mPa.s (Brookfield LVT T-bar spindle, E, rpm 6, 1 min.)Viscosity 43,000 mPa.s (Brookfield LVT T-bar spindle, E, rpm 6, 1 min.)
Beispiel 7Example 7
W/O/W Face moisturiser (zweistufige Herstellung)W / O / W face moisturizer (two-stage production)
Zusammensetzung:Composition:
Primär-Emulsion W/OPrimary emulsion W / O
% W/W% W / W
ArlaceM MO 3.3ArlaceM MO 3.3
Arlacel 2064 3.0Arlacel 2064 3.0
Arlamol HD 15.0Arlamol HD 15.0
Arlamol' M812 14.0Arlamol ' M812 14.0
B Wasser 63.7 Germaben II 1.0 Sekundär-Emulsion W/O/WB water 63.7 Germaben II 1.0 Secondary emulsion W / O / W
A. Primär- Emulsion W/O 50.0A. Primary emulsion W / O 50.0
B. 'Arlatone 2121 5.0 Water 44.1B. 'Arlatone 2121 5.0 Water 44.1
Keltrol 0.4Keltrol 0.4
C. Germaben II 0.5C. Germaben II 0.5
Herstellung:Manufacturing:
Primär-Emulsion W/OPrimary emulsion W / O
1. Langsam wird B zu A unter intensivem Rühren hinzugefügt.1. Slowly add B to A with vigorous stirring.
2. Die erhaltene Mischung wird für weitere 5 Minuten homogenisiert..2. The mixture obtained is homogenized for a further 5 minutes.
Sekundär-Emulsion W/O/WSecondary emulsion W / O / W
1. Die unter B angegebene Zusammensetzung wird mit Ausnahme von Keltrol auf eine Temperatur von 80°C erwärmt. Keltrol wird unter Rüh- ren bei konstanter Temperatur in der vorgelegten Zusammensetzung dispergiert.1. The composition specified under B is heated to a temperature of 80 ° C. with the exception of Keltrol. Keltrol is dispersed with stirring at constant temperature in the submitted composition.
Die beiden getrennt hergestellten Zusammensetzungen A und B werden wie oben beschrieben in einem Mikromischer vermischt.The two separately prepared compositions A and B are mixed in a micromixer as described above.
2. In die auf eine Temperatur unterhalb von 40°C abgekühlte Emulsion wird C hinzugefügt.2. C is added to the emulsion, which has cooled to a temperature below 40 ° C.
3.. Unter leichtem Rühren wird auf Raumtemperatur abgekühlt..3 .. Cool to room temperature with gentle stirring.
Bemerkungen::Remarks::
Viskosität 16.000 mPa.s (Brookfield LVT, T- ) spindle D, rpm 6, min.) Viscosity 16,000 mPa.s (Brookfield LVT, T-) spindle D, rpm 6, min.)

Claims

P A T E N T A N S P R U C H E PATENT CLAIMS
1. Verfahren zur Herstellung von kosmetischen oder pharmazeutischen Formulierungen unmittelbar vor der Verwendung, dadurch gekenn- zeichnet, daß zwei oder mehrere flüssige Komponenten aus getrennten1. Process for the production of cosmetic or pharmaceutical formulations immediately before use, characterized in that two or more liquid components from separate
Vorratskammern miteinander vermischt werden, indem sie durch einen Mikromischer geführt werden.Pantry chambers are mixed together by passing them through a micromixer.
2. Verfahren zur Herstellung von kosmetischen Formulierungen dadurch gekennzeichnet, dadurch gekennzeichnet, daß zwei oder mehrere2. Process for the production of cosmetic formulations characterized in that two or more
Komponenten aus getrennten Vorratskammern, gegebenenfalls nach Erwärmen, in flüssiger Form zum Vermischen durch einen Mikromischer geführt werden.Components from separate storage chambers, if necessary after heating, are passed through a micromixer in liquid form for mixing.
3. Verfahren gemäß der Ansprüche 1 bis 2, dadurch gekennzeichnet, daß zwei oder mehrere Komponenten aus getrennten Vorratskammern, gegebenenfalls nach Erwärmen, in flüssiger Form zum Vermischen durch einen temperierten Mikromischer geführt werden und nachgerührt werden.3. The method according to claims 1 to 2, characterized in that two or more components from separate storage chambers, optionally after heating, are passed in liquid form for mixing through a temperature-controlled micromixer and are subsequently stirred.
4. Verfahren zur Herstellung von kosmetischen Formulierungen in Form von Emulsionen unmittelbar vor der Verwendung, dadurch gekennzeichnet, daß eine oder mehrere flüssige Komponente(n) mit einem oder mehreren natürlichen, synthetischen oder semisynthetischen Öl(en) aus getrennten Vorratskammern miteinander vermischt werden, indem sie durch einen Mikromischer geführt werden.4. Process for the production of cosmetic formulations in the form of emulsions immediately before use, characterized in that one or more liquid components are mixed with one or more natural, synthetic or semi-synthetic oils from separate storage chambers by they are passed through a micromixer.
5. Verfahren zur Herstellung von kosmetischen Formulierungen in Form von Emulsionen unmittelbar vor der Verwendung, dadurch gekenn- zeichnet, daß eine Fettphase, bestehend aus einem oder mehreren natürlichen, synthetischen oder semisynthetischen Öl(en) und einem oder mehreren bei Raumtemperatur festen Fett(en), in einer Vorratskammer durch Erwärmen verflüssigt wird, und diese flüssige Fettphase mit einer oder mehreren flüssige Komponente(n) und gegebenenfalls mit einer weiteren Ölphase vermischt wird, indem sie durch einen Mikromischer geführt werden. 5. Process for the production of cosmetic formulations in the form of emulsions immediately before use, characterized in that a fat phase consisting of one or more natural, synthetic or semi-synthetic oil (s) and one or more fat (s) solid at room temperature ), is liquefied in a storage chamber by heating, and this liquid fat phase is mixed with one or more liquid components and optionally with a further oil phase by passing them through a micromixer.
6. Verfahren gemäß der Ansprüche 1 bis 5, dadurch gekennzeichnet, daß die zu vermischenden Komponenten aus den Vorratskammern gepumpt und durch sich anschließende dünne Röhrchen, welche jeweils in einem Kanal eines Mikromischer enden, in den Mikromischer geleitet werden und aufgrund des durch das Pumpen sich aufbauenden Drucks durch die Kanäle der Mikromischer unter intensiver Vermischung und Bildung einer Emulsion gedrückt werden.6. The method according to claims 1 to 5, characterized in that the components to be mixed are pumped from the storage chambers and passed through adjoining thin tubes, each of which ends in a channel of a micromixer, into the micromixer and due to the pumping Building pressure is pushed through the channels of the micromixer with intensive mixing and formation of an emulsion.
7. Verfahren gemäß der Ansprüche 1 , 4 bis 6, dadurch gekennzeichnet, daß die zu vermischenden Komponenten aus den unter Druck stehenden Vorratskammern gepumpt, durch sich anschließende dünne Röhrchen, welche jeweils in einem Kanal eines Mikromischer enden, in den Mikromischer geleitet werden und aufgrund des durch das Pumpen sich aufbauenden Drucks durch die Kanäle der Mikromischer unter intensiver Vermischung und Bildung einer Emulsion gedrückt werden.7. The method according to claims 1, 4 to 6, characterized in that the components to be mixed are pumped from the pressurized storage chambers, passed through adjoining thin tubes, each of which ends in a channel of a micromixer, into the micromixer and due to The pressure that builds up during pumping is pushed through the channels of the micromixer with intensive mixing and the formation of an emulsion.
8. Verfahren zur Herstellung von liposomenhalfigen Formulierungen unmittelbar vor der Verwendung, dadurch gekennzeichnet, daß eine oder mehrere flüssige Komponente(n) mit einer Komponente, welche lipo- somenbildende Inhaltsstoffe enthält, aus getrennten Vorratskammern miteinander vermischt werden, indem sie durch einen Mikromischer unter Bildung der gewünschten Liposomen geführt werden.8. Process for the production of liposome-containing formulations immediately before use, characterized in that one or more liquid components are mixed with a component which contains liposome-forming ingredients from separate storage chambers by passing them through a micromixer to form of the desired liposomes.
9. Verfahren zur Herstellung von liposomenhalfigen Formulierungen ge- maß Anspruch 8 dadurch gekennzeichnet, daß eine oder mehrere der zu vermischenden Komponente(n) vor der Herstellung der Formulierung erwärmt wird (werden).9. A process for producing liposome-containing formulations according to claim 8, characterized in that one or more of the component(s) to be mixed is (are) heated before the formulation is produced.
10. Verfahren gemäß der Ansprüche 8 bis 9, dadurch gekennzeichnet, daß dadurch gekennzeichnet, daß die zu vermischenden Komponenten aus den Vorratskammern gepumpt und durch sich anschließende dünne Röhrchen, welche jeweils in einem Kanal eines Mikromischer enden, in den Mikromischer geleitet werden und aufgrund des durch das Pumpen sich aufbauenden Drucks durch die Kanäle der Mikromi- scher unter intensiver Vermischung und Bildung einer liposomenhalfigen Formulierung gedrückt werden. 10. The method according to claims 8 to 9, characterized in that the components to be mixed are pumped from the storage chambers and passed into the micromixer through adjoining thin tubes, each of which ends in a channel of a micromixer, and due to the by pumping building up pressure through the channels of the micromixer with intensive mixing and formation of a liposome-containing formulation.
1. Verfahren gemäß der Ansprüche 8 bis 10, dadurch gekennzeichnet, daß die zu vermischenden Komponenten aus unter Druck stehenden Vorratskammern gepumpt und durch sich anschließende dünne Röhrchen, welche jeweils in einem Kanal eines Mikromischer enden, in den Mikromischer geleitet werden und aufgrund des durch das Pumpen sich aufbauenden Drucks durch die Kanäle der Mikromischer unter intensiver Vermischung und Bildung einer liposomenhalfigen Formulierung gedrückt werden.1. The method according to claims 8 to 10, characterized in that the components to be mixed are pumped from pressurized storage chambers and passed through adjoining thin tubes, each of which ends in a channel of a micromixer, into the micromixer and due to the Pumps of building up pressure are pushed through the channels of the micromixer with intensive mixing and formation of a liposome-containing formulation.
12. Lotion oder Lösung, hergestellt nach einem Verfahren gemäß der Ansprüche 1 bis 11.12. Lotion or solution prepared by a method according to claims 1 to 11.
13. Emulsion, hergestellt nach einem Verfahren gemäß der Ansprüche 1 bis 11.13. Emulsion produced by a process according to claims 1 to 11.
14. Gel, hergestellt nach einem Verfahren gemäß der Ansprüche 1 bis 11.14. Gel, produced by a process according to claims 1 to 11.
15. Creme, hergestellt nach einem Verfahren gemäß der Ansprüche 1 bis 11. 15. Cream, produced by a process according to claims 1 to 11.
PCT/EP2000/001974 1999-03-17 2000-03-07 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use WO2000054735A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002367391A CA2367391A1 (en) 1999-03-17 2000-03-07 Process for the preparation of cosmetic or pharmaceutical formulations using a micromixer
JP2000604813A JP2002538947A (en) 1999-03-17 2000-03-07 Method for preparing cosmetic or pharmaceutical formulations using a micromixer
AU39611/00A AU768399B2 (en) 1999-03-17 2000-03-07 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use
EP00918767A EP1161221A1 (en) 1999-03-17 2000-03-07 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19911777.2 1999-03-17
DE19911777A DE19911777A1 (en) 1999-03-17 1999-03-17 Process for the preparation of cosmetic formulations

Publications (1)

Publication Number Publication Date
WO2000054735A1 true WO2000054735A1 (en) 2000-09-21

Family

ID=7901216

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/001974 WO2000054735A1 (en) 1999-03-17 2000-03-07 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use

Country Status (7)

Country Link
EP (1) EP1161221A1 (en)
JP (1) JP2002538947A (en)
CN (1) CN1344145A (en)
AU (1) AU768399B2 (en)
CA (1) CA2367391A1 (en)
DE (1) DE19911777A1 (en)
WO (1) WO2000054735A1 (en)

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10333924B3 (en) * 2003-07-25 2004-10-07 Wella Ag Packaging system for multicomponent products (e.g. cosmetics or pharmaceuticals) requiring mixing immediately before use, comprises assembly of static micro-mixers
EP1508276A1 (en) * 2003-08-21 2005-02-23 Rohm and Haas Company Process for preparing biocide formulations in the form of emulsion
EP1508363A1 (en) * 2003-08-21 2005-02-23 Rohm And Haas Company Process for treating aqueous systems
JP2006507921A (en) * 2002-06-28 2006-03-09 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Method and apparatus for fluid dispersion
US8052704B2 (en) 2000-12-20 2011-11-08 Foxhollow Technologies, Inc. High capacity debulking catheter with distal driven cutting wheel
US8192452B2 (en) 2009-05-14 2012-06-05 Tyco Healthcare Group Lp Easily cleaned atherectomy catheters and methods of use
US8226674B2 (en) 2000-12-20 2012-07-24 Tyco Healthcare Group Lp Debulking catheters and methods
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US8414604B2 (en) 2008-10-13 2013-04-09 Covidien Lp Devices and methods for manipulating a catheter shaft
US8496677B2 (en) 2009-12-02 2013-07-30 Covidien Lp Methods and devices for cutting tissue
US8597315B2 (en) 1999-08-19 2013-12-03 Covidien Lp Atherectomy catheter with first and second imaging devices
US8765485B2 (en) 2003-08-27 2014-07-01 President And Fellows Of Harvard College Electronic control of fluidic species
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
US8808186B2 (en) 2010-11-11 2014-08-19 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
US8920450B2 (en) 2010-10-28 2014-12-30 Covidien Lp Material removal device and method of use
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US8998937B2 (en) 1999-08-19 2015-04-07 Covidien Lp Methods and devices for cutting tissue
US9017623B2 (en) 2007-02-06 2015-04-28 Raindance Technologies, Inc. Manipulation of fluids and reactions in microfluidic systems
US9028512B2 (en) 2009-12-11 2015-05-12 Covidien Lp Material removal device having improved material capture efficiency and methods of use
US9038919B2 (en) 2003-04-10 2015-05-26 President And Fellows Of Harvard College Formation and control of fluidic species
US9068699B2 (en) 2007-04-19 2015-06-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US9119662B2 (en) 2010-06-14 2015-09-01 Covidien Lp Material removal device and method of use
US9328344B2 (en) 2006-01-11 2016-05-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US9687266B2 (en) 2009-04-29 2017-06-27 Covidien Lp Methods and devices for cutting and abrading tissue
US9801647B2 (en) 2006-05-26 2017-10-31 Covidien Lp Catheter including cutting element and energy emitting element
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
US10213224B2 (en) 2014-06-27 2019-02-26 Covidien Lp Cleaning device for catheter and catheter including the same
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US10639597B2 (en) 2006-05-11 2020-05-05 Bio-Rad Laboratories, Inc. Microfluidic devices
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10732649B2 (en) 2004-07-02 2020-08-04 The University Of Chicago Microfluidic system
US11077415B2 (en) 2011-02-11 2021-08-03 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US11635427B2 (en) 2010-09-30 2023-04-25 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
US11786872B2 (en) 2004-10-08 2023-10-17 United Kingdom Research And Innovation Vitro evolution in microfluidic systems
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10100721A1 (en) * 2001-01-10 2002-07-11 Beiersdorf Ag Stable, aqueous UV-protective cosmetic or dermatological preparation, contains benzimidazole-sulfonic acid derivative UV filter, water-soluble preservative and water-soluble or -dispersible dye
DE10208265A1 (en) * 2002-02-26 2003-09-11 Beiersdorf Ag Continuous production of cosmetic and/or dermatological compositions, containing temperature-sensitive components, comprises emulsification, addition of sensitive components and then homogenization
EP1356857B1 (en) * 2002-04-16 2006-06-21 Fuchs Lubritech Gmbh Method for producing and applying of emulsifier free oil-in-water dispersions as a release agent or cooling lubricant
DE10219523A1 (en) * 2002-05-02 2003-11-13 Wella Ag Process for the technical production of hair or skin cosmetic products using equipment with microstructure units
WO2005058477A1 (en) * 2003-12-16 2005-06-30 Unilever Plc Microfluidic device
JP2007152280A (en) * 2005-12-07 2007-06-21 Kao Corp Manufacturing method of hydrogel particle, and composite particle manufacturing apparatus used for the same
DE102007039005A1 (en) * 2007-08-14 2009-02-19 Beiersdorf Ag Micro-emulsion, useful as transparent/translucent cosmetic product or in transparent/translucent cosmetic product preparation, and to prepare skin/hair care product, comprises emulsifying agent and/or co-emulsifying agent
DE102007039007A1 (en) * 2007-08-14 2009-02-19 Beiersdorf Ag Preparation of transparent or translucent emulsion, useful as cosmetic/in cosmetic preparation, and in skin and hair care product to clean the skin and hair, comprises conducting oil phase comprising silicon and water phase by micro-mixer
DE102007057131A1 (en) 2007-11-26 2009-05-28 Beiersdorf Ag Preparing an emulsion, useful e.g. as sun protection- or make-up-preparation and as repellents to protect against mosquitoes, comprises mixing fat- and water-phase containing a solid material in a micromixer and emulsifying the mixture
KR101130932B1 (en) 2009-11-12 2012-03-29 곽영열 Manufacture system for emulsion using an air
DE102010046931A1 (en) * 2010-09-29 2012-03-29 Sanderstrothmann Gmbh Process for the preparation of a cosmetic product
EP2875803A1 (en) * 2013-11-26 2015-05-27 OTC GmbH Polyol-in-oil-emulsions for dermal delivery
FR3039396B1 (en) * 2015-07-28 2017-08-11 Laboratoires M&L BASE OF CONCENTRATED COSMETIC FORMULATION
US11534778B2 (en) 2016-09-30 2022-12-27 Amorepacific Corporation Device for preparing cosmetic composition containing emulsion material instantly emulsified based on microfluidic channel
KR102371209B1 (en) * 2017-03-24 2022-03-07 (주)아모레퍼시픽 Apparatus for manufacturing cosmetic using instantaneous emulsification and maufacturing method of cosmetic using instantaneous emulsification
CN115770273A (en) * 2022-10-10 2023-03-10 重庆大学附属肿瘤医院 A topical Chinese medicinal liniment, and its preparation method and equipment

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0202359A2 (en) * 1985-05-23 1986-11-26 Block Drug Company Inc. Dental preparation, article and method for storage and delivery thereof
EP0704199A1 (en) * 1994-04-20 1996-04-03 The Green Cross Corporation Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation
EP0564672B1 (en) * 1992-04-06 1996-06-19 Baxter International Inc. Aqueous solution for peritoneal dialysis
DE19511603A1 (en) * 1995-03-30 1996-10-02 Norbert Dr Ing Schwesinger Device for mixing small amounts of liquid
DE19611270A1 (en) * 1996-03-22 1997-09-25 Gesim Ges Fuer Silizium Mikros Micro-mixer for very small volumes of liquids or suspensions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2059421A (en) * 1979-10-03 1981-04-23 Self C H Assay method and reagents therefor
US4405489A (en) * 1981-01-15 1983-09-20 Carter-Wallace, Inc. Production of a post-foaming gel and system therefor
DE3230289A1 (en) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen PRODUCTION OF PHARMACEUTICAL OR COSMETIC DISPERSIONS
US5593508A (en) * 1991-02-11 1997-01-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Moist, absorbent material for cleaning articles and surfaces
EP0729746A1 (en) * 1995-02-28 1996-09-04 Unilever Plc Vitamin C delivery system
JP2975943B2 (en) * 1996-02-20 1999-11-10 農林水産省食品総合研究所長 Emulsion manufacturing method and emulsion manufacturing apparatus
DE19746585A1 (en) * 1997-10-22 1999-04-29 Merck Patent Gmbh Coupling for micro components with parallel plates
DE19746583A1 (en) * 1997-10-22 1999-04-29 Merck Patent Gmbh Micro-mixer for liquid, viscous or gaseous phases
DE19746584A1 (en) * 1997-10-22 1999-04-29 Merck Patent Gmbh Micro-mixer housing
DE19854096A1 (en) * 1998-11-24 2000-05-25 Merck Patent Gmbh Connection carrier for plate shaped micro-components, comprises at least one carrier rail fixed to a carrier plate, with a slot for a micro-component insert edge.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0202359A2 (en) * 1985-05-23 1986-11-26 Block Drug Company Inc. Dental preparation, article and method for storage and delivery thereof
EP0564672B1 (en) * 1992-04-06 1996-06-19 Baxter International Inc. Aqueous solution for peritoneal dialysis
EP0704199A1 (en) * 1994-04-20 1996-04-03 The Green Cross Corporation Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation
DE19511603A1 (en) * 1995-03-30 1996-10-02 Norbert Dr Ing Schwesinger Device for mixing small amounts of liquid
DE19611270A1 (en) * 1996-03-22 1997-09-25 Gesim Ges Fuer Silizium Mikros Micro-mixer for very small volumes of liquids or suspensions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1161221A1 *

Cited By (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US9532799B2 (en) 1999-08-19 2017-01-03 Covidien Lp Method and devices for cutting tissue
US9615850B2 (en) 1999-08-19 2017-04-11 Covidien Lp Atherectomy catheter with aligned imager
US9486237B2 (en) 1999-08-19 2016-11-08 Covidien Lp Methods and devices for cutting tissue
US8998937B2 (en) 1999-08-19 2015-04-07 Covidien Lp Methods and devices for cutting tissue
US8911459B2 (en) 1999-08-19 2014-12-16 Covidien Lp Debulking catheters and methods
US10022145B2 (en) 1999-08-19 2018-07-17 Covidien Lp Methods and devices for cutting tissue
US9788854B2 (en) 1999-08-19 2017-10-17 Covidien Lp Debulking catheters and methods
US8597315B2 (en) 1999-08-19 2013-12-03 Covidien Lp Atherectomy catheter with first and second imaging devices
US8052704B2 (en) 2000-12-20 2011-11-08 Foxhollow Technologies, Inc. High capacity debulking catheter with distal driven cutting wheel
US9241733B2 (en) 2000-12-20 2016-01-26 Covidien Lp Debulking catheter
US8226674B2 (en) 2000-12-20 2012-07-24 Tyco Healthcare Group Lp Debulking catheters and methods
US8469979B2 (en) 2000-12-20 2013-06-25 Covidien Lp High capacity debulking catheter with distal driven cutting wheel
US7708949B2 (en) 2002-06-28 2010-05-04 President And Fellows Of Harvard College Method and apparatus for fluid dispersion
US8337778B2 (en) 2002-06-28 2012-12-25 President And Fellows Of Harvard College Method and apparatus for fluid dispersion
US8986628B2 (en) 2002-06-28 2015-03-24 President And Fellows Of Harvard College Method and apparatus for fluid dispersion
JP2006507921A (en) * 2002-06-28 2006-03-09 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Method and apparatus for fluid dispersion
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US20150283546A1 (en) 2003-04-10 2015-10-08 President And Fellows Of Harvard College Formation and control of fluidic species
US10293341B2 (en) 2003-04-10 2019-05-21 President And Fellows Of Harvard College Formation and control of fluidic species
US9038919B2 (en) 2003-04-10 2015-05-26 President And Fellows Of Harvard College Formation and control of fluidic species
US11141731B2 (en) 2003-04-10 2021-10-12 President And Fellows Of Harvard College Formation and control of fluidic species
US8961546B2 (en) 2003-04-22 2015-02-24 Covidien Lp Methods and devices for cutting tissue at a vascular location
US9999438B2 (en) 2003-04-22 2018-06-19 Covidien Lp Methods and devices for cutting tissue at a vascular location
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
DE10333924B3 (en) * 2003-07-25 2004-10-07 Wella Ag Packaging system for multicomponent products (e.g. cosmetics or pharmaceuticals) requiring mixing immediately before use, comprises assembly of static micro-mixers
WO2005018785A1 (en) 2003-07-25 2005-03-03 Wella Aktiengesellschaft Multi-constituent packaging comprising a static micromixer
EP1508276A1 (en) * 2003-08-21 2005-02-23 Rohm and Haas Company Process for preparing biocide formulations in the form of emulsion
EP1508363A1 (en) * 2003-08-21 2005-02-23 Rohm And Haas Company Process for treating aqueous systems
US8765485B2 (en) 2003-08-27 2014-07-01 President And Fellows Of Harvard College Electronic control of fluidic species
US9789482B2 (en) 2003-08-27 2017-10-17 President And Fellows Of Harvard College Methods of introducing a fluid into droplets
US11383234B2 (en) 2003-08-27 2022-07-12 President And Fellows Of Harvard College Electronic control of fluidic species
US10625256B2 (en) 2003-08-27 2020-04-21 President And Fellows Of Harvard College Electronic control of fluidic species
US9878325B2 (en) 2003-08-27 2018-01-30 President And Fellows Of Harvard College Electronic control of fluidic species
US10732649B2 (en) 2004-07-02 2020-08-04 The University Of Chicago Microfluidic system
US11786872B2 (en) 2004-10-08 2023-10-17 United Kingdom Research And Innovation Vitro evolution in microfluidic systems
US9328344B2 (en) 2006-01-11 2016-05-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9410151B2 (en) 2006-01-11 2016-08-09 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9534216B2 (en) 2006-01-11 2017-01-03 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US10639597B2 (en) 2006-05-11 2020-05-05 Bio-Rad Laboratories, Inc. Microfluidic devices
US10588653B2 (en) 2006-05-26 2020-03-17 Covidien Lp Catheter including cutting element and energy emitting element
US9801647B2 (en) 2006-05-26 2017-10-31 Covidien Lp Catheter including cutting element and energy emitting element
US11666355B2 (en) 2006-05-26 2023-06-06 Covidien Lp Catheter including cutting element and energy emitting element
US9017623B2 (en) 2007-02-06 2015-04-28 Raindance Technologies, Inc. Manipulation of fluids and reactions in microfluidic systems
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US9440232B2 (en) 2007-02-06 2016-09-13 Raindance Technologies, Inc. Manipulation of fluids and reactions in microfluidic systems
US10603662B2 (en) 2007-02-06 2020-03-31 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US9068699B2 (en) 2007-04-19 2015-06-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US11224876B2 (en) 2007-04-19 2022-01-18 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US10357772B2 (en) 2007-04-19 2019-07-23 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US10960397B2 (en) 2007-04-19 2021-03-30 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US10675626B2 (en) 2007-04-19 2020-06-09 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US11618024B2 (en) 2007-04-19 2023-04-04 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
US9445834B2 (en) 2008-02-25 2016-09-20 Covidien Lp Methods and devices for cutting tissue
US10219824B2 (en) 2008-02-25 2019-03-05 Covidien Lp Methods and devices for cutting tissue
US11534727B2 (en) 2008-07-18 2022-12-27 Bio-Rad Laboratories, Inc. Droplet libraries
US11596908B2 (en) 2008-07-18 2023-03-07 Bio-Rad Laboratories, Inc. Droplet libraries
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US9192406B2 (en) 2008-10-13 2015-11-24 Covidien Lp Method for manipulating catheter shaft
US10507037B2 (en) 2008-10-13 2019-12-17 Covidien Lp Method for manipulating catheter shaft
US8414604B2 (en) 2008-10-13 2013-04-09 Covidien Lp Devices and methods for manipulating a catheter shaft
US10555753B2 (en) 2009-04-29 2020-02-11 Covidien Lp Methods and devices for cutting and abrading tissue
US9687266B2 (en) 2009-04-29 2017-06-27 Covidien Lp Methods and devices for cutting and abrading tissue
US8192452B2 (en) 2009-05-14 2012-06-05 Tyco Healthcare Group Lp Easily cleaned atherectomy catheters and methods of use
US9220530B2 (en) 2009-05-14 2015-12-29 Covidien Lp Easily cleaned atherectomy catheters and methods of use
US8574249B2 (en) 2009-05-14 2013-11-05 Covidien Lp Easily cleaned atherectomy catheters and methods of use
US9687267B2 (en) 2009-12-02 2017-06-27 Covidien Lp Device for cutting tissue
US10499947B2 (en) 2009-12-02 2019-12-10 Covidien Lp Device for cutting tissue
US8496677B2 (en) 2009-12-02 2013-07-30 Covidien Lp Methods and devices for cutting tissue
US9913659B2 (en) 2009-12-11 2018-03-13 Covidien Lp Material removal device having improved material capture efficiency and methods of use
US9028512B2 (en) 2009-12-11 2015-05-12 Covidien Lp Material removal device having improved material capture efficiency and methods of use
US10751082B2 (en) 2009-12-11 2020-08-25 Covidien Lp Material removal device having improved material capture efficiency and methods of use
US10808279B2 (en) 2010-02-12 2020-10-20 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9119662B2 (en) 2010-06-14 2015-09-01 Covidien Lp Material removal device and method of use
US9855072B2 (en) 2010-06-14 2018-01-02 Covidien Lp Material removal device and method of use
US11635427B2 (en) 2010-09-30 2023-04-25 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
US10952762B2 (en) 2010-10-28 2021-03-23 Covidien Lp Material removal device and method of use
US8920450B2 (en) 2010-10-28 2014-12-30 Covidien Lp Material removal device and method of use
US9717520B2 (en) 2010-10-28 2017-08-01 Covidien Lp Material removal device and method of use
US9326789B2 (en) 2010-11-11 2016-05-03 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
US8808186B2 (en) 2010-11-11 2014-08-19 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
US11077415B2 (en) 2011-02-11 2021-08-03 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11768198B2 (en) 2011-02-18 2023-09-26 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11747327B2 (en) 2011-02-18 2023-09-05 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11754499B2 (en) 2011-06-02 2023-09-12 Bio-Rad Laboratories, Inc. Enzyme quantification
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US10335188B2 (en) 2011-09-01 2019-07-02 Covidien Lp Methods of manufacture of catheter with helical drive shaft
US9770259B2 (en) 2011-09-01 2017-09-26 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US9579157B2 (en) 2012-09-13 2017-02-28 Covidien Lp Cleaning device for medical instrument and method of use
US10434281B2 (en) 2012-09-13 2019-10-08 Covidien Lp Cleaning device for medical instrument and method of use
US10406316B2 (en) 2012-09-13 2019-09-10 Covidien Lp Cleaning device for medical instrument and method of use
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
US10932811B2 (en) 2012-11-08 2021-03-02 Covidien Lp Tissue-removing catheter with rotatable cutter
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US10213224B2 (en) 2014-06-27 2019-02-26 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop

Also Published As

Publication number Publication date
AU768399B2 (en) 2003-12-11
EP1161221A1 (en) 2001-12-12
JP2002538947A (en) 2002-11-19
AU3961100A (en) 2000-10-04
CA2367391A1 (en) 2000-09-21
DE19911777A1 (en) 2000-09-21
CN1344145A (en) 2002-04-10

Similar Documents

Publication Publication Date Title
EP1161221A1 (en) Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use
EP1159076B1 (en) Packaging system for cosmetic formulations
EP0907345B1 (en) Dual phase skin care compositions
EP0969803B1 (en) Emulsifier-free finely dispersed systems of the water-in-oil type
DE602004012213T2 (en) Make-up composition containing nonionic surfactant and ionic surfactant emulsion and solid particles
EP2814451B1 (en) Stable water-in-oil emulsions with spreadable oils
DE60320380T2 (en) COENZYM Q10 FORMULATIONS
EP1773283B1 (en) Highly concentrated self-emulsifying emulsion bases used for the production of oil-in-water emulsions
EP2155148A2 (en) Surfactant-free foam formulations
EP2020221A1 (en) DMS (Derma Membrane Structure) in foaming creams
EP1140008A1 (en) Cosmetic or pharmaceutical gels which contain lecithin, or low viscosity o/w microemulsions which contain lecithin
DE102012002950A1 (en) Stable water in oil emulsions with HLB-like emulsifiers
EP1003463B1 (en) Cosmetic compositions with agglomerated substrates
DE202005011885U1 (en) Foamed preparation from particle shaped material, useful e.g. in cosmetic preparation, comprises a composition containing a surfactant and a thickening agent in liquid medium
KR101259452B1 (en) Nanoemulsion emulsifier and cosmetic composition comprising the same
EP2066310B1 (en) Emulsions comprising rubber arabicum
EP1641904A2 (en) O/w emulsifier, o/w emulsion and applications thereof
DE102005035398B4 (en) Foamed preparation, process for its preparation, device and use
DE102018217678A1 (en) Cosmetic foam suitable for crucible products and their manufacture
EP2142015A2 (en) Emulsion preconcentrates and micellar formulations containing wood resins
JPS59173124A (en) Emulsified composition
DE102012202337A1 (en) Stable water in oil emulsions with improved sensors
DE102010021688A1 (en) Process for the preparation of a micellar active substance concentrate
DE10303944B4 (en) Cosmetic composition
WO2010022524A1 (en) Emulsion preconcentrates, and micellar formulations comprising cyclodextrin

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00805116.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2000918767

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2000 604813

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2367391

Country of ref document: CA

Ref document number: 2367391

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09936660

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 39611/00

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2000918767

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 39611/00

Country of ref document: AU

WWR Wipo information: refused in national office

Ref document number: 2000918767

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000918767

Country of ref document: EP